Diabetes and cardiovascular disease (CVD) are both global epidemics. They are currently among the leading causes of morbidity and mortality worldwide, particularly affecting populations in low- and middle-income populations. Their negative effects are accelerated by globalization, rapid unplanned urbanization and increasingly sedentary lifestyles.
Taking Diabetes to Heart is a multi-country study, developed by the International Diabetes Federation (IDF) in partnership with Novo Nordisk, focused on CVD awareness and knowledge among people living with type 2 diabetes. The study - the first of its kind in the world - builds on the IDF global report on Diabetes and Cardiovascular Disease (2016), which includes recommendations to reduce the burden of CVD among people with diabetes and the general population.
Taking Diabetes to Heart consists of an online survey, available in multiple languages, targeted at people living with type 2 diabetes. The survey was open until 31 May 2018.
The aim of Taking Diabetes to Heart is to define the actions that are required to promote knowledge and awareness of cardiovascular disease among people living with type 2 diabetes, to improve their health outcomes and address systemic challenges to healthcare systems.
Results from the survey will be used to inform policy and decision-making around this common and serious complication of diabetes. The study will culminate with a comprehensive report with country specific results and a set of resources related to diabetes and CVD in particular countries and around the world.
Interim results of Taking Diabetes to Heart were presented at the IDF Congress 2017 in Abu Dhabi, UAE. Read more.